A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-κB signaling and Paget's disease of bone with a severe phenotype

被引:74
作者
Rea, Sarah L.
Walsh, John P.
Ward, Lynley
Yip, Kirk
Ward, Bryan K.
Kent, G. Neil
Steer, James H.
Xu, Jiake
Ratajczak, Thomas
机构
[1] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Western Australian Inst Med Res, Mol Endocrinol Lab, Nedlands, WA 6009, Australia
[3] Univ Western Australia, UWA Ctr Med Ctr, Nedlands, WA 6009, Australia
[4] Univ Western Australia, Sch Surg & Pathol, Mol Orthopaed Lab, Nedlands, WA 6009, Australia
[5] Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Clin Pathol, Nedlands, WA 6009, Australia
[6] Univ Western Australia, Sch Med & Pharmacol, Pharmacol Unit, Nedlands, WA 6009, Australia
关键词
Paget's disease of bone; SQSTM1/p62; NF-kappa B; osteoclastogenesis; ubiquitin binding associated domain;
D O I
10.1359/JBMR.060405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Sequestosome 1/p62 (p62) mutations are associated with Paget's disease of bone (PDB); however, there are limited data regarding functional consequences. One report has linked the common P392L mutation in the p62 ubiquitin binding associated (UBA) domain with increases in NF-kappa B activity, a transcription factor essential for osteoclastogenesis. To further clarify the functional impact of p62 mutations associated with PDB, we assessed the effect of p62 mutation (a novel mutation: K378X, and previously reported mutations: P392L and E396X) on RANK-induced NF-kappa B activation and compared this with the effect of wildtype p62. In addition, we studied the effect of p62 mutation on osteoclast formation and bone resorption. Materials and Methods: We performed co-transfection experiments with expression plasmids for p62 (wildtype or mutated) and RANK and an NF-kappa B luciferase reporter gene. Luciferase activities were recorded after addition of luciferin to cellular lysates. RAW(264.7) cells stably expressing enhanced green fluorescent protein (EGFP)-tagged p62 (wildtype, K378X, or P392L) or EGFP alone were assessed for changes in cell proliferation. Additionally, these cells were stimulated with RANKL to produce osteoclast-like cells (OLCs). Primary human monocytes collected from the K378X-affected patient and a control subject were stimulated to form OLCs and bone resorption data were obtained. Results: The novel mutation introduces a premature stop codon in place of Lys-378 and thereby eliminates the entire p62 UBA domain; this and two additional natural mutations (P392L, E396X) increased NF-kappa B activation compared with wildtype p62. Wildtype p62 consistently inhibited NF-kappa B activation compared with empty vector. UBA mutations (K378X and P392L) significantly increased the number of OLCs formed in response to RANKL and also the number of nuclei of the OLCs. K378X-affected human monocytes formed more OLCs with more nuclei and increased bone resorption compared with control monocytes. Conclusions: Our data show that mutation of the p62 UBA domain results in increased activation of NF-kappa B and osteoclast formation and function compared with wildtype p62. These results may partially explain the mechanism by which p62 mutation contributes to the pathogenesis of PDB.
引用
收藏
页码:1136 / 1145
页数:10
相关论文
共 30 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis [J].
Durán, A ;
Serrano, M ;
Leitges, M ;
Flores, JM ;
Picard, S ;
Brown, JP ;
Moscat, J ;
Diaz-Meco, MT .
DEVELOPMENTAL CELL, 2004, 6 (02) :303-309
[4]   Familial Paget's disease in The Netherlands - Occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations [J].
Eekhoff, EWM ;
Karperien, M ;
Houtsma, D ;
Zwinderman, AH ;
Dragoiescu, C ;
Kneppers, ALJ ;
Papapoulos, SE .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1650-1654
[5]   Two novel mutations at exon 8 of the sequestosome 1 (SQSTM1) gene in an Italian series of patients affected by Paget's disease of bone (PDB) [J].
Falchetti, A ;
Di Stefano, M ;
Marini, F ;
Del Monte, F ;
Mavilia, C ;
Strigoli, D ;
De Feo, ML ;
Isaia, G ;
Masi, L ;
Amedei, A ;
Cioppi, F ;
Ghinoi, V ;
Bongi, SM ;
Di Fede, G ;
Sferrazza, C ;
Rini, GB ;
Melchiorre, D ;
Matucci-Cerinic, M ;
Brandi, ML .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (06) :1013-1017
[6]   Association of the atypical protein kinase C-interacting protein p62/ZIP with nerve growth factor receptor TrkA regulates receptor trafficking and Erk5 signaling [J].
Geetha, T ;
Wooten, MW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) :4730-4739
[7]   Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees [J].
Good, DA ;
Busfield, F ;
Fletcher, BH ;
Lovelock, PK ;
Duffy, DL ;
Kesting, JB ;
Andersen, J ;
Shaw, JTE .
BONE, 2004, 35 (01) :277-282
[8]   Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: A 2-year study [J].
Gutteridge, DH ;
Retallack, RW ;
Ward, LC ;
Stuckey, BGA ;
Stewart, GO ;
Prince, RL ;
Kent, GN ;
Bhagat, CI ;
Price, RI ;
Thompson, RI ;
Nicholson, GC .
BONE, 1996, 19 (04) :387-394
[9]   Novel UBA domain mutations of SQSTM1 in Paget's disease of bone:: Genotype phenotype correlation, functional analysis, and structural consequences [J].
Hocking, LJ ;
Lucas, GJA ;
Daroszewska, A ;
Cundy, T ;
Nicholson, GC ;
Donath, J ;
Walsh, JP ;
Finlayson, C ;
Cavey, JR ;
Ciani, B ;
Sheppard, PW ;
Searle, MS ;
Layfield, R ;
Ralston, SH .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1122-1127
[10]   Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease [J].
Hocking, LJ ;
Lucas, GJA ;
Daroszewska, A ;
Mangion, J ;
Olavesen, M ;
Cundy, T ;
Nicholson, GC ;
Ward, L ;
Bennett, ST ;
Wuyts, W ;
Van Hul, W ;
Ralston, SH .
HUMAN MOLECULAR GENETICS, 2002, 11 (22) :2735-2739